Spyre Therapeutics Inc. (SYRE) short volume · $7.60B cap
Spyre Therapeutics Inc. FINRA short-volume cache. Latest 2026-09-08.
| Date | Short | Total | Short % |
|---|---|---|---|
| 2026-09-08 | 320,342 | 526,451 | 60.8% |
| 2026-09-04 | 164,864 | 301,148 | 54.7% |
| 2026-09-03 | 179,115 | 395,302 | 45.3% |
| 2026-09-02 | 221,684 | 531,384 | 41.7% |
| 2026-09-01 | 198,630 | 466,863 | 42.5% |
| 2026-08-31 | 395,175 | 695,697 | 56.8% |
| 2026-08-28 | 270,018 | 482,017 | 56.0% |
| 2026-08-27 | 334,457 | 499,397 | 67.0% |
| 2026-08-26 | 1,012,348 | 1,584,724 | 63.9% |
| 2026-08-25 | 120,423 | 197,905 | 60.8% |
FAQ
What is SYRE P/E and revenue?
Spyre Therapeutics Inc. (SYRE) $7.60B cap.
What is SYRE short volume?
Spyre Therapeutics Inc. last cached short volume is 60.8% of total volume on 2026-09-08.
Not investment advice. Cached rows, not a live tape.